April 2025

OPHTHALMOLOGY

AGE-RELATED MACULAR DEGENERATION: TREATMENTS AND TRIALS

Manjot K. Gill, MD, discusses non-exudative macular degeneration with geographic atrophy. She highlights recent FDA-approved treatments and an exciting phase 2 clinical trial on fatty acid synthase inhibition. This innovative approach aims to reduce inflammation and improve treatment durability, and it has the potential to transform the management of this condition.
Manjot K. Gill, MD, Professor of Ophthalmology at Northwestern Medicine

Refer a Patient

Northwestern Medicine welcomes the opportunity to collaborate with you in caring for your patients. ​

You May Also Like